The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Trigoni, Anastasia  [Clear All Filters]
Journal Article
Kyriakou, A., Trigoni A., Galanis N., Sotiriadis D., & Patsatsi A. (2018).  Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data.. Dermatol Reports. 10(2), 7859.
Kyrgidis, A., Athanassios K., Tzellos T-G., Trigoni A., & Triaridis S. (2013).  p16 post-hoc analyses and Simpson's paradox.. Lancet Oncol. 14(11), e436.
Lazaridou, E., Giannopoulou C., APALLA Z., Fotiadou C., Trigoni A., & Ioannides D. (2010).  Parry-Romberg syndrome.. J Dermatol Case Rep. 4(2), 30-2.
Apalla, Z., Sotiriou E., Lazaridou E., Manousari A., Trigoni A., Papagarifallou I., et al. (2013).  Pemphigus vegetans of the tongue: a diagnostic and therapeutic challenge.. Int J Dermatol. 52(3), 350-1.
Lazaridou, E., Giannopoulou C., Fotiadou C., Vakirlis E., Trigoni A., & Ioannides D. (2011).  The potential role of microorganisms in the development of rosacea.. J Dtsch Dermatol Ges. 9(1), 21-5.
Lazaridou, E., Fotiadou C., Tsorova C., Trachana M., Trigoni A., Patsatsi A., et al. (2010).  Resistant pityriasis lichenoides et varioliformis acuta in a 3-year-old boy: successful treatment with methotrexate.. Int J Dermatol. 49(2), 215-7.
Tzellos, T., Kyrgidis A., Vakirlis E., & Trigoni A. (2014).  Secukinumab for ankylosing spondylitis.. Lancet. 383(9919), 780.
Patsatsi, A., Lamprou F., Kokolios M., Stylianidou D., Trigoni A., Kalampalikis D., et al. (2017).  Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.. Acta Dermatovenerol Croat. 25(3), 195-201.
Patsatsi, A., Kyriakou A., Meltzanidou P., Trigoni A., Lamprou F., Kokolios M., et al. (2018).  Βullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?. Eur J Dermatol. 28(5), 711-713.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.